• 31 Citations
  • 2 h-Index
20132015
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Juli D. Williams is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Simvastatin Medicine & Life Sciences
Pharmacists Medicine & Life Sciences
Metformin Medicine & Life Sciences
Vitamin B 12 Medicine & Life Sciences
Chronic Obstructive Pulmonary Disease Medicine & Life Sciences
Disease Progression Medicine & Life Sciences
Macrocytic Anemia Medicine & Life Sciences
Incidence Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2013 2015

  • 31 Citations
  • 2 h-Index
  • 3 Article
  • 1 Short survey

Comparison of patients receiving long-term metformin therapy and Vitamin B12 monitoring

Farland, M. Z., McPheeters, C. M., Renwick, R. C., Barlow, P. B., Williams, J., Keeble, D. & Franks, A., Jan 1 2015, In : Journal of Pharmacy Technology. 31, 4, p. 184-189 6 p.

Research output: Contribution to journalArticle

Metformin
Vitamin B 12
Macrocytic Anemia
Peripheral Nervous System Diseases
Serum

Impact of pharmacists' interventions and simvastatin dose restrictions

Shoulders, B. R., Franks, A., Barlow, P. B., Williams, J. & Farland, M. Z., Jan 1 2014, In : Pharmaceutical Care Espana. 16, 6, 1 p.

Research output: Contribution to journalShort survey

Simvastatin
Pharmacists
2 Citations (Scopus)

Impact of Pharmacists' Interventions and Simvastatin Dose Restrictions

Shoulders, B. R., Franks, A., Barlow, P. B., Williams, J. & Farland, M. Z., Jan 1 2014, In : Annals of Pharmacotherapy. 48, 1, p. 54-61 8 p.

Research output: Contribution to journalArticle

Simvastatin
Pharmacists
United States Food and Drug Administration
LDL Lipoproteins
Drug Labeling
29 Citations (Scopus)

Uso de bloqueadores-β y la incidencia de exacerbaciones de la enfermedad obstructiva pulmonar crónica

Translated title of the contribution: β-blocker use and incidence of chronic obstructive pulmonary disease exacerbationsFarland, M. Z., Peters, C. J., Williams, J., Bielak, K., Heidel, R. & Chamberlin, S., May 1 2013, In : Annals of Pharmacotherapy. 47, 5, p. 651-656 6 p.

Research output: Contribution to journalArticle

Chronic Obstructive Pulmonary Disease
Disease Progression
Incidence
Adrenergic Antagonists
Hospitalization